October Effect’s Milestone Pharmaceuticals MIST Stock Holding History

October Effect’s Portfolio MIST Stock Details MIST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$34.6K	Hold	40,000	–	–	0.04%	62
2026 Q2	$53.6K	Sell	40,000 -11,950	-23%	-$19.1K	0.05%	64
2026 Q1	$61.8K	Sell	51,950 -150	-0.3%	-$263	0.07%	63
2025 Q4	$105K	Buy	+52,100	New	+$112K	0.12%	61

Other funds holding MIST

RVW Wealth Los Angeles, California $1.56B AUM 16.49% 1-Year Est. Return

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.14% 1-Year Est. Return

Secure Asset Management Troy, Michigan $753M AUM 20.9% 1-Year Est. Return

Atlantic Edge Private Wealth Management Jacksonville, Florida $487M AUM 24.51% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

October Effect's MIST Position: Q3 2026 in Review

October Effect held its Milestone Pharmaceuticals (MIST) position steady in Q3 2026 at 40,000 shares worth $34.6K. The position accounts for 0.04% of the portfolio, ranked #62.

October Effect first reported a position in MIST in Q4 2025 and has held it in 4 quarters since. The position peaked at $105K in Q4 2025. 6 funds tracked by Wall St. Rank hold MIST as of Q3 2026.

October Effect held 40,000 shares of Milestone Pharmaceuticals worth $34.6K as of Q3 2026.
October Effect left its Milestone Pharmaceuticals share count unchanged in Q3 2026.
Milestone Pharmaceuticals made up 0.04% of October Effect's portfolio in Q3 2026, its #62 holding.
October Effect first reported a position in Milestone Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
October Effect's Milestone Pharmaceuticals position peaked at $105K in Q4 2025.
6 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q3 2026.

Based on October Effect's 13F filing for Q3 2026, filed 20 Oct 2026.